Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu

Measuring Self-Efficacy on Portuguese Respiratory Patients on Pulmonary Rehabilitation (PRAISEPort)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03875599
Recruitment Status : Completed
First Posted : March 15, 2019
Last Update Posted : March 21, 2019
Sponsor:
Collaborators:
Centro Hospitalar Lisboa Norte
Fundação para a Ciência e a Tecnologia
Information provided by (Responsible Party):
Catarina Santos, University of Lisbon

Brief Summary:
This study aimed to translate and adapt to portuguese an original british instrument useful to measure respiratory patients' self-efficacy specific to the context of Pulmonary Rehabilitation.

Condition or disease Intervention/treatment
Pulmonary Rehabilitation Other: Pulmonary Rehabilitation

Detailed Description:
Recent updates on Pulmonary Rehabilitation highlight the importance of patients' self-efficacy on long-term adherence to health-enhancing behaviors. The Pulmonary Rehabilitation Adapted Index of Self-Efficacy (PRAISE) is an adaptation of the General Self-Efficacy Scale. This study aimed to translate, culturally adapt and evaluate reliability and validity of PRAISE on Portuguese respiratory patients.Forward-backward translation and pilot testing were performed. Content validity was assessed by a multidisciplinary panel of expert judges. To evaluate reliability and validity, 150 respiratory outpatients on Pulmonary Rehabilitation participated on a cross-sectional study. Descriptive and reliability analyses, and exploratory factorial analysis using principal axis factoring, followed by oblique oblimin factor rotation were conducted to identify construct validity. IBM® SPSS® version 22 was used to perform statistical analysis.

Layout table for study information
Study Type : Observational
Actual Enrollment : 150 participants
Observational Model: Cohort
Time Perspective: Cross-Sectional
Official Title: Validation of the Pulmonary Rehabilitation Adapted Index of Self-Efficacy on Portuguese Respiratory Patients
Actual Study Start Date : January 19, 2018
Actual Primary Completion Date : November 23, 2018
Actual Study Completion Date : November 23, 2018

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Rehabilitation


Intervention Details:
  • Other: Pulmonary Rehabilitation
    Respiratory Physiotherapy, Exercise Therapy, Patient Education


Primary Outcome Measures :
  1. Patients' self-efficacy [ Time Frame: 2 weeks ]
    Vincent and co-authors (2011) proposed the Pulmonary Rehabilitation Adapted Index of Self-Efficacy (PRAISE). The PRAISE tool is composed by a total of 15 items, combining 10 items from the General Self-Efficacy Scale (GSE) by Schwarzer and Jerusalem (1995), and 5 new specific items related to Pulmonary Rehabilitation. Each item is scored from 1 to 4 with a total range from 15 to 60, with higher scores indicating higher levels of self-efficacy. Araújo and Moura (2011) already validated a Portuguese version of the GSE, yet the assessment of self-efficacy remains to be explored on the Portuguese Pulmonary Rehabilitation setting. This study translated, culturally adapted and evaluated reliability and validity of PRAISE on Portuguese respiratory patients, with original author's permission. Hence, items 4, 7, 9, 12 and 15 were specific to Pulmonary Rehabilitation as proposed by PRAISE original authors, and the remaining items and answer key were in accordance with the portuguese GSE.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   26 Years to 89 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
150 adults attending an outpatient Pulmonary Rehabilitation program based at Hospital Pulido Valente from Centro Hospitalar Universitário de Lisboa Norte, in Lisbon, Portugal.
Criteria

Inclusion Criteria:

  • Patients with acute respiratory disease
  • Patients with chronic respiratory disease
  • Patients attending a hospital-based Pulmonary Rehabilitation program

Exclusion Criteria:

• Cognitive deficit for answering a questionnaire


Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03875599


Locations
Layout table for location information
Portugal
Instituto Nacional de Saúde Doutor Ricardo Jorge, Departamento de Epidemiologia
Lisboa, Portugal, 1600-560
Universidade de Lisboa, Faculdade de Medicina, Instituto de Saúde Ambiental (ISAMB)
Lisboa, Portugal, 1649-028
Centro Hospitalar Universitário Lisboa Norte, Hospital Pulido Valente, Unidade de Reabilitação Respiratória
Lisboa, Portugal, 1649-035
Instituto Politécnico de Lisboa, Escola Superior de Tecnologia da Saúde de Lisboa, Unidade de Ensino e Investigação em Psicologia e Sociologia
Lisboa, Portugal, 1990-094
Sponsors and Collaborators
University of Lisbon
Centro Hospitalar Lisboa Norte
Fundação para a Ciência e a Tecnologia
Investigators
Layout table for investigator information
Principal Investigator: Catarina D Santos, MSc University of Lisbon
Study Director: Cristina Bárbara, PhD University of Lisbon

Layout table for additonal information
Responsible Party: Catarina Santos, PhD student, Physiotherapist MSc, University of Lisbon
ClinicalTrials.gov Identifier: NCT03875599     History of Changes
Other Study ID Numbers: 46/17
First Posted: March 15, 2019    Key Record Dates
Last Update Posted: March 21, 2019
Last Verified: March 2019
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No

Keywords provided by Catarina Santos, University of Lisbon:
self-efficacy
instrument validity
PRAISE